Best TWAS P=7.18e-10 · Best GWAS P=3.01e-09 conditioned to 0.295
| # | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GTEx | Adipose Visceral Omentum | FES | 0.21 | 0.09 | lasso | 5 | 0.05 | 1.3e-03 | 5.9 | -5.8 | 6.4e-09 | -0.99 | 0.00 | 1.00 | FALSE |
| 2 | GTEx | Artery Tibial | FES | 0.16 | 0.04 | lasso | 5 | 0.05 | 4.8e-05 | 4.9 | -5.9 | 4.9e-09 | -0.89 | 0.00 | 1.00 | FALSE |
| 3 | GTEx | Cells Transformed fibroblasts | FES | 0.28 | 0.17 | enet | 21 | 0.20 | 2.8e-15 | 5.9 | -5.7 | 1.2e-08 | -0.92 | 0.00 | 1.00 | FALSE |
| 4 | GTEx | Lung | FES | 0.24 | 0.07 | lasso | 6 | 0.05 | 5.1e-05 | 4.9 | -5.5 | 3.1e-08 | -0.90 | 0.00 | 1.00 | FALSE |
| 5 | GTEx | Skin Sun Exposed Lower leg | FES | 0.09 | 0.04 | lasso | 5 | 0.04 | 1.4e-04 | 5.9 | -5.7 | 1.3e-08 | -0.91 | 0.00 | 0.99 | FALSE |
| 6 | GTEx | Thyroid | FES | 0.33 | 0.19 | lasso | 6 | 0.18 | 4.3e-14 | 5.4 | -5.5 | 4.5e-08 | -0.95 | 0.01 | 0.99 | FALSE |
| 7 | METSIM | Adipose | FES | 0.08 | 0.06 | lasso | 3 | 0.05 | 6.8e-08 | 5.1 | -5.3 | 1.2e-07 | -0.88 | 0.04 | 0.95 | FALSE |
| 8 | YFS | Blood | FES | 0.31 | 0.11 | enet | 77 | 0.22 | 1.2e-68 | 5.9 | -5.2 | 1.6e-07 | -0.61 | 0.00 | 1.00 | FALSE |
| 9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.06 | 1.9e-05 | 4.9 | -5.5 | 2.9e-08 | -0.74 | 0.02 | 0.96 | FALSE |
| 10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.07 | 7.4e-14 | 5.9 | -6.2 | 7.2e-10 | -0.88 | 0.00 | 1.00 | TRUE |
| 11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FES | 0.06 | 0.03 | blup | 46 | 0.05 | 5.6e-06 | 4.7 | -5.7 | 1.3e-08 | -0.78 | 0.01 | 0.99 | FALSE |
| 12 | The Cancer Genome Atlas | Lung Adenocarcinoma | FES | 0.05 | 0.04 | lasso | 2 | 0.04 | 2.2e-05 | 5.9 | -5.9 | 3.3e-09 | -0.95 | 0.00 | 1.00 | FALSE |
| 13 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FES | 0.08 | 0.07 | enet | 7 | 0.08 | 4.2e-09 | 5.9 | -5.4 | 8.3e-08 | -0.93 | 0.00 | 1.00 | FALSE |
| 14 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FES | 0.13 | 0.16 | lasso | 2 | 0.14 | 6.1e-10 | 5.9 | -5.8 | 8.0e-09 | -0.99 | 0.00 | 1.00 | FALSE |
| 15 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FES | 0.12 | 0.09 | lasso | 5 | 0.08 | 4.1e-09 | 5.9 | -6.1 | 1.2e-09 | -0.95 | 0.00 | 1.00 | FALSE |
| 16 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FES | 0.32 | 0.26 | lasso | 2 | 0.25 | 2.0e-09 | 5.7 | -5.7 | 1.2e-08 | -0.96 | 0.00 | 1.00 | FALSE |
| 17 | The Cancer Genome Atlas | Thyroid Carcinoma | FES | 0.30 | 0.30 | lasso | 7 | 0.32 | 1.3e-31 | 5.7 | -5.9 | 2.9e-09 | -0.95 | 0.00 | 1.00 | FALSE |